SCHEMBL20415885

SCHEMBL20415885

CC(C)(C)OC(=O)N[C@@H](Cc1ccc(Cl)cc1)c1nn[nH]n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRN P28799 1/20 0.47
SORT1 Q99523 1/20 0.47
PIN1 Q13526 3/20 0.45
ITGB1 P05556 1/20 0.43
ITGA4 P13612 1/20 0.43
ITGB7 P26010 1/20 0.43
ALDH1A1 P00352 3/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
MME P08473 2/20 0.43
LMNA P02545 2/20 0.43
PKM P14618 2/20 0.43
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
AGTR1 P30556 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16856563 0.89 PIN1 (0.57) PIN1ALDH1A1MMELMNAPKM
SCHEMBL20204233 0.89 PIN1 (0.57) PIN1ALDH1A1MMELMNAPKM
SCHEMBL28562554 0.88 PIN1 (0.47) PIN1ITGB1ITGA4ITGB7ALDH1A1
SCHEMBL20415886 0.88 PIN1 (0.47) PIN1ITGB1ITGA4ITGB7ALDH1A1
SCHEMBL20397780 0.82 PIN1 (0.54) GRNSORT1PIN1ITGB1ITGA4
SCHEMBL20397778 0.82 PIN1 (0.54) GRNSORT1PIN1ITGB1ITGA4
SCHEMBL18762450 0.78 GRN (0.58) GRNSORT1PIN1ALDH1A1LMNA
SCHEMBL18762452 0.78 GRN (0.58) GRNSORT1PIN1ALDH1A1LMNA
SCHEMBL20415765 0.78 ECE1 (0.40) GRNSORT1PIN1ALDH1A1MME
SCHEMBL18271631 0.77 FPR2 (0.46) ALDH1A1PPARGPPARALMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858314-B2 Urea derivative or pharmacologically acceptable salt thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2020-12-08 US disclosed
US-20180208552-A1 UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF KYORIN PHARMACEUTICAL CO., LTD. (JP) 2018-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10858314-B2 Urea derivative or pharmacologically acceptable salt thereof FPR1, SAAL1, FPR2 GRN 303/4885SORT1 154/4885PIN1 3515/4885
US-20180208552-A1 UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF FPR1, FPR2, SAAL1 GRN 257/4885SORT1 156/4885PIN1 3357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.